Vertex Pharmaceuticals
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
What If You Bought VRTX Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Aug 24, 2000 | $72.53 | 2-for-1 | 2× | 2× |
Vertex Pharmaceuticals Market Cap Timeline
Validated annual market-cap history is available from 1996. Split markers cover all 1 recorded split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.